tradingkey.logo

DSS Inc

DSS
0.935USD
+0.016+1.79%
交易中 美東報價延遲15分鐘
8.50M總市值
虧損本益比TTM

DSS Inc

0.935
+0.016+1.79%

關於 DSS Inc 公司

DSS, Inc. is a multinational, public company. The Company operates its business through five divisions: Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. The Product Packaging division operates through Premier Packaging Corporation, Inc., which markets, manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through its operating company, American Pacific Bancorp, Inc., which represents its banking and financing business line. The Direct Marketing is specialized in marketing and distributing its products and services through its subsidiary and partner network, using the gig economic marketing strategy as a form of direct marketing.

DSS Inc簡介

公司代碼DSS
公司名稱DSS Inc
上市日期Oct 27, 1993
CEOGrady (Jason)
員工數量100
證券類型Ordinary Share
年結日Oct 27
公司地址275 Wiregrass Pkwy
城市WEST HENRIETTA
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編14586
電話15852321500
網址https://www.dssworld.com/
公司代碼DSS
上市日期Oct 27, 1993
CEOGrady (Jason)

DSS Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--
Mr. Tung Moe Chan
Mr. Tung Moe Chan
Director
Director
--
--
Mr. Todd D. Macko
Mr. Todd D. Macko
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Shui Yeung (Frankie) Wong, CPA
Mr. Shui Yeung (Frankie) Wong, CPA
Independent Director
Independent Director
--
--
Ms. Hiu Pan (Joanne) Wong
Ms. Hiu Pan (Joanne) Wong
Independent Director
Independent Director
--
--
Mr. Sheng Hon (Danny) Lim
Mr. Sheng Hon (Danny) Lim
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Jason Grady
Mr. Jason Grady
Interim Chief Executive Officer
Interim Chief Executive Officer
125.00
--
Mr. Jose Escudero
Mr. Jose Escudero
Independent Director
Independent Director
51.00
--
Mr. Heng Fai (Ambrose) Chan
Mr. Heng Fai (Ambrose) Chan
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. Wai Leung (William) Wu
Mr. Wai Leung (William) Wu
Lead Independent Director
Lead Independent Director
--
--
Mr. Tung Moe Chan
Mr. Tung Moe Chan
Director
Director
--
--
Mr. Todd D. Macko
Mr. Todd D. Macko
Chief Financial Officer
Chief Financial Officer
--
--

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2023
FY2023Q1
FY2022
FY2022Q1
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Packaging Printing and Fabrication
484.10K
7.57%
Commercial and Security Printing
78.00K
1.22%
Real Property Rental Income
16.00K
0.25%
由於公司未披露,未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
Packaging Printing and Fabrication
484.10K
7.57%
Commercial and Security Printing
78.00K
1.22%
Real Property Rental Income
16.00K
0.25%

股東統計

更新時間: 1月31日 週六
更新時間: 1月31日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Alset Ehome International Inc
36.04%
Chan (Heng Fai Ambrose)
20.31%
Global Biomedical Pte Ltd.
3.08%
The Vanguard Group, Inc.
0.64%
Renaissance Technologies LLC
0.31%
其他
39.63%
持股股東
持股股東
佔比
Alset Ehome International Inc
36.04%
Chan (Heng Fai Ambrose)
20.31%
Global Biomedical Pte Ltd.
3.08%
The Vanguard Group, Inc.
0.64%
Renaissance Technologies LLC
0.31%
其他
39.63%
股東類型
持股股東
佔比
Corporation
39.11%
Individual Investor
20.31%
Investment Advisor
0.85%
Hedge Fund
0.34%
Investment Advisor/Hedge Fund
0.23%
Research Firm
0.03%
其他
39.13%

機構持股

更新時間: 12月8日 週一
更新時間: 12月8日 週一
報告期間
機構數
持股數
持股佔比
持股變動
2025Q4
35
146.29K
1.44%
-88.95K
2025Q3
36
145.92K
2.15%
-17.92K
2025Q2
35
163.84K
2.17%
-884.00
2025Q1
35
164.73K
1.72%
+7.88K
2024Q4
38
121.90K
3.03%
-50.52K
2024Q3
42
172.42K
3.04%
-10.61K
2024Q2
46
183.03K
2.83%
+19.66K
2024Q1
49
163.37K
2.83%
-36.31K
2023Q4
48
186.92K
3.41%
+16.51K
2023Q3
52
170.94K
7.14%
-2.49K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Alset Ehome International Inc
3.65M
40.14%
-581.39K
-13.74%
Oct 06, 2025
Chan (Heng Fai Ambrose)
2.06M
22.62%
--
--
Oct 06, 2025
Global Biomedical Pte Ltd.
311.63K
3.43%
--
--
Oct 06, 2025
The Vanguard Group, Inc.
64.83K
0.71%
+43.10K
+198.36%
Sep 30, 2025
Renaissance Technologies LLC
31.45K
0.35%
+4.00K
+14.57%
Sep 30, 2025
Geode Capital Management, L.L.C.
22.84K
0.25%
+3.65K
+18.99%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
20.98K
0.23%
--
--
Sep 30, 2025
Citi Investment Research (US)
2.94K
0.03%
+2.94K
--
Sep 30, 2025
Tower Research Capital LLC
2.54K
0.03%
-1.89K
-42.63%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
公告日期
除權除息日
類型
比率
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
Nov 08, 2023
Merger
20→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
May 05, 2020
Merger
30→1
KeyAI